Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:1487-1493

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hébert, R.
Right arrow Articles by Dubois, M.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hébert, R.
Right arrow Articles by Dubois, M.-F.
Related Collections
Right arrow Risk Factors
Right arrow Behavioral Changes and Stroke
Right arrow Primary and Secondary Stroke Prevention
Right arrow Other Stroke

(Stroke. 2000;31:1487.)
© 2000 American Heart Association, Inc.


Original Contributions

Vascular Dementia

Incidence and Risk Factors in the Canadian Study of Health and Aging

Réjean Hébert, MD, MPhil; Joan Lindsay, PhD; René Verreault, MD, PhD; Kenneth Rockwood, MD; Gerry Hill, MD Marie-France Dubois, PhD

From the Sherbrooke Geriatric University Institute, Sherbrooke, Quebec (R.H., M.F.D.); the Laboratory Centre for Disease Control, Health Canada, Ottawa, Ontario (J.L.); Laval University, Québec City, Quebec (R.V.); Sisters of Charity of Ottawa Health Service Inc, Ottawa, Ontario (G.H.); and Dalhousie University, Halifax, Nova Scotia (K.R.), Canada.

Correspondence to Dr Réjean Hébert, Gerontology and Geriatrics Research Centre, 1036 Belvédère Sud, Sherbrooke, Quebec, J1H 4C4, Canada. E-mail rhebert{at}courrier.usherb.ca

Background and Purpose—Very few population-based studies have systematically examined incident vascular dementia (VaD). From the Canadian Study of Health and Aging cohort, incidence rates of VaD were determined and risk factors analyzed.

Methods—This was a cohort incidence study that followed 8623 subjects presumed to be free of dementia over a 5-year period. The risk factors were examined with a nested prospective case-control study. Exposure was determined by means of a risk factor questionnaire administered to the subject or a proxy at the beginning of the study.

Results—On the basis of 38 476 person-years at risk, the annual incidence rate was estimated to be 2.52 per thousand undemented Canadians (95% CI 2.02 to 3.02). Including an estimation of the probability of VaD among the decedents, this figure rose to 3.79. For the risk factors study, 105 incident cases of VaD according to the NINCDS-AIREN criteria were compared with 802 control subjects. Significant risk factors were: age (OR=1.05), residing in a rural area (2.03), living in an institution (2.33), diabetes (2.15), depression (2.41), apolipoprotein E {epsilon}4 (2.34), hypertension for women (2.05), heart problems for men (2.52), taking aspirin (2.33), and occupational exposure to pesticides or fertilizers (2.05). Protective factors were eating shellfish (0.46) and regular exercise for women (0.46). There was no relation with sex, education, or alcohol.

Conclusions—The study confirmed some previously reported risk factors but also suggested new ones. It raised concerns about the prescription of aspirin and perhaps other factors related to rural life.


Key Words: cerebrovascular disorders • epidemiology • cohort • case-control




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
C. H Rojas-Fernandez and P. Moorhouse
Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications
Ann. Pharmacother., July 1, 2009; 43(7): 1310 - 1323.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
P. Y. Takahashi, L. N. Dyrbye, K. G. Thomas, O. Quirindongo Cedeno, F. North, R. J. Stroebel, R. S. DeJesus, and P. V. Targonski
The Association of Transient Ischemic Attack Symptoms With Memory Impairment Among Elderly Participants of the Third US National Health and Nutrition Examination Survey
J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 46 - 51.
[Abstract] [PDF]


Home page
Age AgeingHome page
R. Peters, J. Peters, J. Warner, N. Beckett, and C. Bulpitt
Alcohol, dementia and cognitive decline in the elderly: a systematic review
Age Ageing, September 1, 2008; 37(5): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
D S KNOPMAN
Cerebrovascular disease and dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S121 - S127.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Di Carlo, M. Lamassa, M. Baldereschi, M. Inzitari, E. Scafato, G. Farchi, D. Inzitari, and For the Italian Longitudinal Study on Aging Workin
CIND and MCI in the Italian elderly: Frequency, vascular risk factors, progression to dementia
Neurology, May 29, 2007; 68(22): 1909 - 1916.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. S. Silbert, D. A. Scott, L. A. Evered, M. S. Lewis, and P. T. Maruff
Preexisting Cognitive Impairment in Patients Scheduled for Elective Coronary Artery Bypass Graft Surgery
Anesth. Analg., May 1, 2007; 104(5): 1023 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M. Guizzetti and L. Costa
Cholesterol homeostasis in the developing brain: a possible new target for ethanol
Human and Experimental Toxicology, April 1, 2007; 26(4): 355 - 360.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. A. Luchsinger, B. Patel, M.-X. Tang, N. Schupf, and R. Mayeux
Measures of Adiposity and Dementia Risk in Elderly Persons
Arch Neurol, March 1, 2007; 64(3): 392 - 398.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
R. Lekwauwa, D. McQuoid, and D. C. Steffens
Hippocampal Volume Is Associated With Physician-Reported Acute Cognitive Deficits After Electroconvulsive Therapy
J Geriatr Psychiatry Neurol, March 1, 2006; 19(1): 21 - 25.
[Abstract] [PDF]


Home page
Mayo Clin Proc.Home page
D. S. Knopman
Dementia and Cerebrovascular Disease
Mayo Clin. Proc., February 1, 2006; 81(2): 223 - 230.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. J. Podewils, E. Guallar, L. H. Kuller, L. P. Fried, O. L. Lopez, M. Carlson, and C. G. Lyketsos
Physical Activity, APOE Genotype, and Dementia Risk: Findings from the Cardiovascular Health Cognition Study
Am. J. Epidemiol., April 1, 2005; 161(7): 639 - 651.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
G.-Y. R. Hsiung, A. D. Sadovnick, and H. Feldman
Apolipoprotein E {epsilon}4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Can. Med. Assoc. J., October 12, 2004; 171(8): 863 - 867.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. den Heijer, S. E Vermeer, E. J van Dijk, N. D Prins, P. J Koudstaal, C. M van Duijn, A. Hofman, and M. M. Breteler
Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 992 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E F J Meulen, B Schmand, J P van Campen, S J de Koning, R W Ponds, P Scheltens, and F R Verhey
The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia
J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 700 - 705.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J.-H. Lin, R.-T. Lin, C.-T. Tai, C.-L. Hsieh, S.-F. Hsiao, and C.-K. Liu
Prediction of poststroke dementia
Neurology, August 12, 2003; 61(3): 343 - 348.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. C.W. van Straaten, P. Scheltens, D. L. Knol, M. A. van Buchem, E. J. van Dijk, P. A.M. Hofman, G. Karas, O. Kjartansson, F.-E. de Leeuw, N. D. Prins, et al.
Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia: An Interobserver Study
Stroke, August 1, 2003; 34(8): 1907 - 1912.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Etminan, S. Gill, and A. Samii
Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies
BMJ, July 17, 2003; 327(7407): 128.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Anttila, E.-L. Helkala, M. Kivipelto, M. Hallikainen, K. Alhainen, H. Heinonen, A. Mannermaa, J. Tuomilehto, H. Soininen, and A. Nissinen
Midlife income, occupation, APOE status, and dementia: A population-based study
Neurology, September 24, 2002; 59(6): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Lindsay, D. Laurin, R. Verreault, R. Hebert, B. Helliwell, G. B. Hill, and I. McDowell
Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging
Am. J. Epidemiol., September 1, 2002; 156(5): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Rockwood, M. Brown, H. Merry, I. Sketris, and J. Fisk
Societal Costs of Vascular Cognitive Impairment in Older Adults
Stroke, June 1, 2002; 33(6): 1605 - 1609.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Peila, B. L. Rodriguez, and L. J. Launer
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies: The Honolulu-Asia Aging Study
Diabetes, April 1, 2002; 51(4): 1256 - 1262.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. B. Posner, M.-X. Tang, J. Luchsinger, R. Lantigua, Y. Stern, and R. Mayeux
The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function
Neurology, April 23, 2000; 58(8): 1175 - 1181.
[Abstract] [Full Text] [PDF]